Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Leissinger, C
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study. [electronic resource] - Thrombosis and haemostasis Sep 2014 - 445-58 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
2567-689X
10.1160/TH14-01-0078 doi
Adolescent
Adult
Antibodies, Blocking--metabolism
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antibody Formation--drug effects
Antigens, CD20--immunology
Blood Coagulation--drug effects
Child
Child, Preschool
Factor VIII--administration & dosage
Follow-Up Studies
Hemophilia A--drug therapy
Humans
Immunosuppressive Agents--administration & dosage
Male
Rituximab
Treatment Outcome
United States
Young Adult
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study. [electronic resource] - Thrombosis and haemostasis Sep 2014 - 445-58 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
2567-689X
10.1160/TH14-01-0078 doi
Adolescent
Adult
Antibodies, Blocking--metabolism
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antibody Formation--drug effects
Antigens, CD20--immunology
Blood Coagulation--drug effects
Child
Child, Preschool
Factor VIII--administration & dosage
Follow-Up Studies
Hemophilia A--drug therapy
Humans
Immunosuppressive Agents--administration & dosage
Male
Rituximab
Treatment Outcome
United States
Young Adult